Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study

BMC Gastroenterology(2021)10.1186/s12876-021-02017-8Source: DataRank Database

Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study is a research paper published in BMC Gastroenterology (2021). On theSindex it has a DataRank of 0. It has been cited 32 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.67)OA: goldTopics (55)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Hannes Hagström ORCID,Rajani Sharma ORCID,Jonas Söderling ORCID,Björn Roelstraete ORCID,Emma Larsson ORCID

Live enrichment

PubMed:34814851 PMC:PMC8609512 OpenAlex:https://openalex.org/W3214901556

NIH

Grant: NIH K23 DK122104

NIDDK NIH HHS

Grant: K23 DK122104

Karolinska Institute

Grant: unidentified

unidentified

National Institutes of Health

Grant: 3K23DK122104-04S1

Aspirin and Novel Lipid Mediators in Nonalcoholic Fatty Liver Disease

Karolinska Institute

Karolinska Institutet

Region Stockholm

FWCI

1.67

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

goldLicense: cc-by

journalhttps://bmcgastroenterol.biomedcentral.com/counter/pdf/10.1186/s12876-021-02017-8

publisherhttps://bmcgastroenterol.biomedcentral.com/counter/pdf/10.1186/s12876-021-02017-8

publisherhttps://link.springer.com/content/pdf/10.1186/s12876-021-02017-8.pdf

publisherhttps://link.springer.com/article/10.1186/s12876-021-02017-8/fulltext.html

journalhttps://doi.org/10.1186/s12876-021-02017-8

Fields of Study

COVID-19 Clinical Research StudiesLiver Disease Diagnosis and TreatmentLiver Disease and Transplantation0301 basic medicine03 medical and health sciences0302 clinical medicineAdultCOVID-19Cohort StudiesHumansLiver CirrhosisNon-alcoholic Fatty Liver DiseaseRisk FactorsSARS-CoV-2

MeSH Terms

COVID-19SARS-CoV-2AdultHumansLiver CirrhosisRisk FactorsCohort StudiesNon-alcoholic Fatty Liver Disease

Keywords

MedicineInternal medicineHazard ratioPopulationLiver diseaseChronic liver diseaseNonalcoholic fatty liver diseaseCohortProportional hazards modelCohort studyGastroenterologyCirrhosisConfidence intervalFatty liverDiseaseSurvivalCorona virusCovidAdultLiver CirrhosisSARS-CoV-2Research610COVID-19RC799-869Diseases of the digestive system. GastroenterologyCohort StudiesCOVID-19 (Disease)Non-alcoholic Fatty Liver DiseaseRisk Factors616HumansLiver--Cirrhosis--Mortality

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study

10.6084/m9.figshare.17073362.v1figshare

Additional file 1 of Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study

10.6084/m9.figshare.17073362figshare